New CFO of the Rodenstock Group: Dr. Mani Herold to join on April 1st

Munich, March 8th 2023 – The Rodenstock Group, a global leader in Vision Care and manufacturer of biometric lenses, will complete its Executive Management Team as of April 1st.

The Executive Management Board will be complemented by Dr. Mani Herold, who joins Rodenstock from the Pfleiderer Group and succeeds Marcus Desimoni in his role as CFO. Dr. Herold has more than 25 years of international work experience in the area of strategic and operational financial management, amongst others at E.ON and Cerdia. Over the past years Dr. Herold has been CFO and Labor Director of the Pfleiderer Group, where he was instrumental in successfully repositioning Pfleiderer in the debt capital markets and in securing the financial performance of the Group during times of highly volatile raw material and energy prices. He holds a Ph. D. and a Master of Business Administration from the University of Munich.

Marcus Desimoni, CEO of Rodenstock says: “We are pleased to welcome with Dr. Herold a well-rounded finance leader to our Rodenstock management team. The breadth of his experience and his leadership skills will allow him to play a decisive role in the future transformational path of the Rodenstock Group.”

Dr. Mani Herold adds: “I am excited joining the Rodenstock Group. With its unique biometric positioning of Rodenstock paired with the ambitious environment of a PE company it is perfectly positioned for future growth.”

About Rodenstock:
The Rodenstock Group is a worldwide leading manufacturer of high-quality ophthalmic lenses. With the philosophy "B.I.G. VISION™ FOR ALL” the lens manufacturer stands for a paradigm shift in individual progressive lenses. The company, which was founded in 1877 with its headquarters in Munich, Germany, employs around 5,100 people worldwide and is represented with sales offices and distribution partners in more than 85 countries. Rodenstock maintains production plants at 16 locations in 15 countries.